IGM Biosciences Inc. (IGMS) Misses Q3 EPS by 21c

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q3 EPS of ($1.01), $0.21 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $520 thousand versus the consensus estimate of $230.56 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• iMetal Resources closes $3M private placement with McFarlane Lake